capsule91

a very positive structure with interesting developments

做多
NSE:AUROPHARMA   AUROBINDO PHARMA
the sandoz acquisition, is going to add 50% of the last fy revenue , with balance sheet leveraged to 0.7 de ratio...

disclaimer... not an investing/trading recommendation
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。